182 related articles for article (PubMed ID: 23378871)
1. Imaging characteristics of an unusual, high-grade angiocentric glioma: a case report and review of the literature.
Aguilar HN; Hung RW; Mehta V; Kotylak T
J Radiol Case Rep; 2012 Oct; 6(10):1-10. PubMed ID: 23378871
[TBL] [Abstract][Full Text] [Related]
2. Malignant glioma with angiocentric features.
Lu JQ; Patel S; Wilson BA; Pugh J; Mehta V
J Neurosurg Pediatr; 2013 Mar; 11(3):350-5. PubMed ID: 23240849
[TBL] [Abstract][Full Text] [Related]
3. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
4. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
5. Diffusion tensor imaging and chemical shift imaging assessment of heterogeneity in low grade glioma under temozolomide chemotherapy.
Sijens PE; Heesters MA; Enting RH; van der Graaf WT; Potze JH; Irwan R; Meiners LC; Oudkerk M
Cancer Invest; 2007 Dec; 25(8):706-10. PubMed ID: 18058466
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging determination of tumor grade and early response to temozolomide in a genetically engineered mouse model of glioma.
McConville P; Hambardzumyan D; Moody JB; Leopold WR; Kreger AR; Woolliscroft MJ; Rehemtulla A; Ross BD; Holland EC
Clin Cancer Res; 2007 May; 13(10):2897-904. PubMed ID: 17504989
[TBL] [Abstract][Full Text] [Related]
7. ADC texture--an imaging biomarker for high-grade glioma?
Brynolfsson P; Nilsson D; Henriksson R; Hauksson J; Karlsson M; Garpebring A; Birgander R; Trygg J; Nyholm T; Asklund T
Med Phys; 2014 Oct; 41(10):101903. PubMed ID: 25281955
[TBL] [Abstract][Full Text] [Related]
8. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.
Poptani H; Gupta RK; Roy R; Pandey R; Jain VK; Chhabra DK
AJNR Am J Neuroradiol; 1995 Sep; 16(8):1593-603. PubMed ID: 7502961
[TBL] [Abstract][Full Text] [Related]
9. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
[TBL] [Abstract][Full Text] [Related]
10. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted MR imaging for the differentiation of true progression from pseudoprogression following concomitant radiotherapy with temozolomide in patients with newly diagnosed high-grade gliomas.
Lee WJ; Choi SH; Park CK; Yi KS; Kim TM; Lee SH; Kim JH; Sohn CH; Park SH; Kim IH
Acad Radiol; 2012 Nov; 19(11):1353-61. PubMed ID: 22884399
[TBL] [Abstract][Full Text] [Related]
12. [Novelties and new possibilities in radiological diagnostics of brain tumors].
Várallyay P
Magy Onkol; 2014 Dec; 58(4):261-8. PubMed ID: 25517444
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury.
Hein PA; Eskey CJ; Dunn JF; Hug EB
AJNR Am J Neuroradiol; 2004 Feb; 25(2):201-9. PubMed ID: 14970018
[TBL] [Abstract][Full Text] [Related]
14. Predictive significance of mean apparent diffusion coefficient value for responsiveness of temozolomide-refractory malignant glioma to bevacizumab: preliminary report.
Nagane M; Kobayashi K; Tanaka M; Tsuchiya K; Shishido-Hara Y; Shimizu S; Shiokawa Y
Int J Clin Oncol; 2014 Feb; 19(1):16-23. PubMed ID: 23354833
[TBL] [Abstract][Full Text] [Related]
15. Differentiation between low-grade and high-grade glioma using combined diffusion tensor imaging metrics.
Ma L; Song ZJ
Clin Neurol Neurosurg; 2013 Dec; 115(12):2489-95. PubMed ID: 24183513
[TBL] [Abstract][Full Text] [Related]
16. Distinction between glioma progression and post-radiation change by combined physiologic MR imaging.
Matsusue E; Fink JR; Rockhill JK; Ogawa T; Maravilla KR
Neuroradiology; 2010 Apr; 52(4):297-306. PubMed ID: 19834699
[TBL] [Abstract][Full Text] [Related]
17. [Pattern of care of high-grade gliomas].
Laigle-Donadey F; Sanson M
Rev Prat; 2006 Oct; 56(16):1779-86. PubMed ID: 17315503
[TBL] [Abstract][Full Text] [Related]
18. Dysembryoplastic neuroepithelial tumors: proton MR spectroscopy, diffusion and perfusion characteristics.
Bulakbasi N; Kocaoglu M; Sanal TH; Tayfun C
Neuroradiology; 2007 Oct; 49(10):805-12. PubMed ID: 17632714
[TBL] [Abstract][Full Text] [Related]
19. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
[TBL] [Abstract][Full Text] [Related]
20. Angiocentric Glioma in an Elderly Patient: Case Report and Review of the Literature.
Gonzalez-Quarante LH; Fernández Carballal C; Agarwal V; Vargas Lopez AJ; Gil de Sagredo Del Corral OL; Sola Vendrell E
World Neurosurg; 2017 Jan; 97():755.e5-755.e10. PubMed ID: 27756673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
